vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $143.3M, roughly 1.5× Piedmont Realty Trust, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -31.4%, a 88.8% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
IDYA vs PDM — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $143.3M |
| Net Profit | $119.2M | $-45.0M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | -31.4% |
| Revenue YoY | — | 0.4% |
| Net Profit YoY | 330.1% | -27.9% |
| EPS (diluted) | $1.33 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $143.3M | ||
| Q4 25 | — | $142.9M | ||
| Q3 25 | $207.8M | $139.2M | ||
| Q2 25 | — | $140.3M | ||
| Q1 25 | — | $142.7M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | $0 | $139.3M | ||
| Q2 24 | $0 | $143.3M |
| Q1 26 | — | $-45.0M | ||
| Q4 25 | — | $-43.2M | ||
| Q3 25 | $119.2M | $-13.5M | ||
| Q2 25 | — | $-16.8M | ||
| Q1 25 | — | $-10.1M | ||
| Q4 24 | — | $-30.0M | ||
| Q3 24 | $-51.8M | $-11.5M | ||
| Q2 24 | $-52.8M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 52.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | -31.4% | ||
| Q4 25 | — | -30.3% | ||
| Q3 25 | 57.4% | -9.7% | ||
| Q2 25 | — | -12.0% | ||
| Q1 25 | — | -7.1% | ||
| Q4 24 | — | -20.9% | ||
| Q3 24 | — | -8.3% | ||
| Q2 24 | — | -6.8% |
| Q1 26 | — | $-0.10 | ||
| Q4 25 | — | $-0.34 | ||
| Q3 25 | $1.33 | $-0.11 | ||
| Q2 25 | — | $-0.14 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | $-0.60 | $-0.09 | ||
| Q2 24 | $-0.68 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $2.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $1.5B |
| Total Assets | $1.2B | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.3M | ||
| Q4 25 | — | $731.0K | ||
| Q3 25 | $786.9M | $3.0M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $2.9M | ||
| Q4 24 | — | $109.6M | ||
| Q3 24 | $920.0M | $133.6M | ||
| Q2 24 | $701.7M | $138.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B |
| Q1 26 | — | $1.5B | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.1B | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $931.7M | $1.7B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | — | $4.0B | ||
| Q3 25 | $1.2B | $4.0B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | $1.2B | $4.1B | ||
| Q2 24 | $973.7M | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 1.41× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | — |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | 110.3% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $140.6M | ||
| Q3 25 | $142.2M | $35.8M | ||
| Q2 25 | — | $50.1M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | $198.1M | ||
| Q3 24 | $-49.2M | $42.9M | ||
| Q2 24 | $-32.9M | $66.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | 110.3% | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
